Clinical and Dosimetric Results of Proton or Photon Radiotherapy for Large >5 cm Hepatocellular Carcinoma
A Retrospective Analysis When dealing with large, inoperable liver tumors (specifically hepatocellular carcinoma, or HCC), choosing the right type of radiation therapy can make a significant difference in patient outcomes. In a recent study published in The Red Journal, researchers aimed to understand the clinical and dosimetric differences between proton therapy and traditional photon therapy in […]
Read MoreProton beam radiotherapy versus TACE for Liver Cancer
A recent study comparing survival rates, recurrence patterns, toxicity, and treatment cost in patients with hepatocellular carcinoma (HCC) treated with either transarterial chemoembolization (TACE) or proton beam radiotherapy (PBT) found that patients treated with PBT required fewer courses of treatment, fewer post-treatment hospitalization days, and reduced cost of treatment compared to TACE. Hepatocellular carcinoma (HCC), […]
Read MoreProton Therapy -A Good Option for Liver Cancer
Studies show Proton Therapy can reduce side effects and increase overall survival for liver cancer. ABOUT LIVER CANCER Liver cancer is the sixth most common cancer worldwide and one of the leading causes of cancer death. In 2019, there were approximately 100,000 people living with liver cancer in the United States. According to the National Cancer […]
Read More